Pfizer, Biontech Get First U.S. EUA Of COVID-19 Vaccine In Adolescents

T-Reuters2021-05-11

Pfizer Inc :Pfizer And Biontech Receive First U.S. Authorization For Emergency Use Of Covid-19 Vaccine In Adolescents.In A Phase 3 Trial, Vaccine Was 100% Effective And Generally Well Tolerated In Participants Aged 12 To 15 Years.Pfizer - Data Also Submitted To European Medicines Agency (Ema) And Other Global Regulators, With Additional Authorizations Expected In Coming Weeks.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
10